Integrin Signaling Mechanisms in Platelet Activation

Integrin αIIbβ3 is the principal adhesion receptor on platelets and serves as a fulcrum for bidirectional signal transduction that underpins haemostasis and thrombosis. In resting platelets, αIIbβ3 resides in a low-affinity conformation. Upon exposure to agonists such as thrombin, ADP or collagen, intracellular mediators including talin and kindlin bind the cytoplasmic tails of αIIbβ3, inducing an allosteric switch to a high-affinity state capable of binding fibrinogen and von Willebrand factor. This “inside-out” activation promotes integrin clustering and initiates “outside-in” signalling cascades that engage Src family kinases, Syk and phospholipase Cγ2, elevate intracellular Ca2+ and reorganise the actin cytoskeleton. Small GTPases such as Rap1, RhoA, Rac1 and Cdc42 coordinate shape change, granule secretion and thrombus consolidation by cycling between GTP-bound active and GDP-bound inactive forms. Cross-talk between integrins and G protein-coupled receptors further refines platelet responses, enabling fine-tuning of aggregation and secretion. Dysregulation of any node in this network predisposes to bleeding disorders or pathological thrombosis, making integrin signalling an attractive target for novel antiplatelet therapies.

Research from Nature Portfolio

A recent study has elucidated a direct inhibitory interaction between the β3 integrin tail and the Gα13-p115RhoGEF complex, revealing a mechanism by which αIIbβ3 selectively dampens G protein-coupled RhoA activation. This work demonstrates that blocking this interaction with a β3-derived peptide can suppress granule secretion without impairing primary aggregation, offering a means to uncouple platelet exocytosis from adhesion. In a mouse model of myocardial ischaemia–reperfusion, the peptide exacerbated injury by limiting secretion-driven inflammation, underscoring the therapeutic potential and physiological importance of integrin–G protein cross-talk.

Integrin Signaling Mechanisms in Platelet Activation publication trend

The graph below shows the total number of articles in integrin signaling mechanisms in platelet activation across all publications each year (not limited to Nature Index journals).

Technical terms

Integrin αIIbβ3: A platelet-specific transmembrane receptor that mediates adhesion and bidirectional signalling by binding extracellular ligands such as fibrinogen.

Inside-out signalling: The process by which intracellular activators (for example talin) induce a conformational change in integrins, increasing ligand affinity.

Outside-in signalling: The cascade of intracellular events triggered when ligands bind activated integrins, leading to kinase activation and cytoskeletal reorganisation.

GTPase: An enzyme that cycles between an active GTP-bound state and an inactive GDP-bound state, transmitting signals for cytoskeletal and vesicular dynamics.

Talin: An intracellular adaptor protein that binds integrin cytoplasmic tails and linkes them to the actin cytoskeleton, essential for inside-out activation.

References

1. Integrin β3 directly inhibits the Gα13-p115RhoGEF interaction to regulate G protein signaling and platelet exocytosis. Nature Communications (2023).
2. Somatic RAP1B gain-of-function variant underlies isolated thrombocytopenia and immunodeficiency. Journal of Clinical Investigation (2024).
3. Rho GTPase Signaling in Platelet Regulation and Implication for Antiplatelet Therapies. International Journal of Molecular Sciences (2023).
4. Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting. Journal of Hematology & Oncology (2019).